Fase preanalítica: punto crítico en las pruebas de diagnóstico hematológico

  • Natalia M. Guevara-Arismendy Laboratorio Clínico Hematológico
  • Verónica J. Tangarife-Castaño Laboratorio Clínico Hematológico
Palabras clave: servicios de laboratorio clínico, hematología, fase preanalítica, mejoramiento de la calidad.

Resumen

La fase preanalítica es un componente importante de los procesos operacionales realizados en los laboratorios clínicos, en la que se desarrollan diversos procedimientos que pueden afectar el resultado de un examen de sangre, tejidos o fluidos corporales de un paciente. Esta fase va desde la orden médica hasta el inicio del procesamiento de la muestra (fase analítica). Específicamente, en el diagnóstico hematológico los exámenes de laboratorio son la principal fuente de información para la toma de decisiones médicas relacionadas con el tratamiento y el seguimiento de los pacientes; por tal razón, el control de todos los aspectos involucrados en la fase preanalítica debe ser una prioridad en todos los laboratorios clínicos. En esta revisión se presentan los principales aspectos preanalíticos de las pruebas más comunes en el diagnóstico hematológico, correspondientes a las áreas de coagulación básica y especializada, hematología general y especializada, citometría de flujo, citogenética, biología molecular, entre otras de interés.

Descargas

La descarga de datos todavía no está disponible.

Biografía del autor/a

Natalia M. Guevara-Arismendy, Laboratorio Clínico Hematológico

Microbióloga y Bioanalista, MSc en Microbiología y Bioanálisis con énfasis en Hematología. Bacterióloga, Laboratorio Clínico Hematológico. Medellín, Colombia.

Verónica J. Tangarife-Castaño , Laboratorio Clínico Hematológico

Microbióloga y Bioanalista, MSc en Ciencias Básicas Biomédicas con énfasis en Microbiología y Parasitología. Coordinadora Científica, Editora Médica Colombiana. Medellín, Colombia.

Referencias bibliográficas

Browning RA. The Labor Shortage, Patient Safety, and Length of Stay: New Era of Change Agents Prompts Process Improvements through Lab Automation. JALA 2004; 9: 24-27.

https://doi.org/10.1016/S1535-5535-03-00106-0

Suardíaz J, Cruz C, Colina A. Laboratorio Clínico. La Habana, Cuba: Editorial Ciencias Médicas; 2004.

Rodríguez-Ravelo MA, Abraham-Marcel E. Las variables preanalíticas y su influencia en los resultados de laboratorio clínico. Rev Mex Patol Clin 2007; 54: 159-167.

Carraro P, Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 2007; 53: 1338-1342.

https://doi.org/10.1373/clinchem.2007.088344

Instituto Colombiano de Normas Técnicas y Certificación (ICONTEC). Laboratorios clínicos. Requisitos generales para la calidad y la competencia. Norma Técnica Colombiana NTC-ISO 15189; 2014.

CLSI. Quality Management System: A Model for Laboratory Services; Approved Guideline-Fourth edition. CLSI document QMS01-A4. Pensilvania, Estados Unidos: Clinical and Laboratory Standards Institute; 2011.

Lippi G, Banfi G, Buttarello M, Ceriotti F, Daves M, Dolci A, et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med 2007; 45: 728-736.

https://doi.org/10.1515/CCLM.2007.174

Kalra J. Medical errors: impact on clinical laboratories and other critical areas. Clin Biochem 2004; 37: 1052-1062.

https://doi.org/10.1016/j.clinbiochem.2004.08.009

Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48: 691-698.

Wiwanitkit V. Types and frequency of preanalytical mistakes in the first Thai ISO 9002:1994 certified clinical laboratory, a 6 - month monitoring. BMC Clin Pathol 2001; 1: 5.

https://doi.org/10.1186/1472-6890-1-5

Nutting PA, Main DS, Fischer PM, Stull TM, Pontious M, Seifert M, Jr., et al. Toward optimal laboratory use. Problems in laboratory testing in primary care. JAMA 1996; 275: 635-639.

https://doi.org/10.1001/jama.1996.03530320059035

Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997; 43: 1348-1351.

Wang S, Ho V. Corrections of clinical chemistry test results in a laboratory information system. Arch Pathol Lab Med 2004; 128: 890-892.

Campuzano-Maya G. Alteraciones del hemograma relacionadas con los contadores de células. Medicina & Laboratorio 2005; 11: 363-384.

Green SF. The cost of poor blood specimen quality and errors in preanalytical processes. Clin Biochem 2013; 46: 1175-1179.

https://doi.org/10.1016/j.clinbiochem.2013.06.001

Picossi-García S, Molina Mendoza P, Pérez Milena A, Aguilera Fuentes C, Espinar Parejo P, Lopera Puerto M. Cumplimiento de 12 horas de ayuno para la realización de análisis de sangre en la zona básica de salud de Archidona. Medicina de Familia (And) 2004; 5: 136-139.

España, Ministerio de Sanidad y Consumo, Instituto Nacional de Gestión Sanitaria. Actualización de la Fase Preanalítica de los Laboratorios Clínicos del Hospital "Cruz Roja" del INGESA de Ceuta Madrid, España. 2007. Disponible: http://www.ingesa.msssi.gob.es/estadEstudios/documPublica/pdf/actualzFasePreanalitica.pdf. Consultado: oct 2016.

McCay L, Lemer C, Wu AW. Laboratory safety and the WHO World Alliance for Patient Safety. Clin Chim Acta 2009; 404: 6-11.

https://doi.org/10.1016/j.cca.2009.03.019

Céspedes-Quevedo MC, Edward-Seringe S. Preparación del paciente y colección de muestras para análisis de Laboratorio Clínico. MEDISAN 1999; 3: 31-35.

Laposata M, Dighe A. "Pre-pre" and "post-post" analytical error: high-incidence patient safety hazards involving the clinical laboratory. Clin Chem Lab Med 2007; 45: 712-719.

https://doi.org/10.1515/CCLM.2007.173

Wallin O, Soderberg J, Van Guelpen B, Stenlund H, Grankvist K, Brulin C. Preanalytical venous blood sampling practices demand improvement--a survey of test-request management, test-tube labelling and information search procedures. Clin Chim Acta 2008; 391: 91-97.

https://doi.org/10.1016/j.cca.2008.02.016

Galban G, Misino S, Wekken MVD, Tomassini L, Suarez M. Errores Pre-analíticos (EPA) en el Laboratorio de Guardia del Hospital Interzonal Especializado Materno Infantil (HIEMI) de la Ciudad de Mar del Plata. Rev Bioanálisis 2007: 18-21.

Lima-Oliveira G, Volanski W, Lippi G, Picheth G, Guidi GC. Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis. Scand J Clin Lab Invest 2017; 77: 153-163.

https://doi.org/10.1080/00365513.2017.1295317

Kumar-Nigam P. Preanalytical Errors: Some common errors in Blood Specimen Collection for routine investigations in hospital patients. J Clin Diagn Res 2011; 5: 659-661.

Stankovic AK, DiLauri E. Quality improvements in the preanalytical phase: focus on urine specimen workflow. Clin Lab Med 2008; 28: 339-350, viii.

https://doi.org/10.1016/j.cll.2007.12.011

Lippi G, Mattiuzzi C, Bovo C, Favaloro EJ. Managing the patient identification crisis in healthcare and laboratory medicine. Clin Biochem 2017; feb 4 [Epub ahead of print].

Henry JB, Kurec AS. Laboratorio clínico: organización, objetivos y práctica. En: Henry JB, ed. Henry - El Laboratorio en el Diagnóstico Clínico. Madrid, España: Marbán; 2005: 3-49.

Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ. Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 2012; 38: 565-575.

https://doi.org/10.1055/s-0032-1315961

Polack B, Schved JF, Boneu B. Preanalytical recommendations of the 'Groupe d'Etude sur l'Hemostase et la Thrombose' (GEHT) for venous blood testing in hemostasis laboratories. Haemostasis 2001; 31: 61-68.

https://doi.org/10.1159/000048046

Blomback M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007; 5: 855-858.

https://doi.org/10.1111/j.1538-7836.2007.02401.x

Favaloro EJ, Lippi G. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med 2010; 48: 309-321.

https://doi.org/10.1515/CCLM.2010.061

Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost 2006; 96: 73-78.

https://doi.org/10.1160/TH06-01-0004

Samama MM, Contant G, Spiro TE, Perzborn E, Le Flem L, Guinet C, et al. Laboratory assessment of rivaroxaban: a review. Thromb J 2013; 11: 11.

https://doi.org/10.1186/1477-9560-11-11

Baglin T, Keeling D, Kitchen S. Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology. Br J Haematol 2012; 159: 427-429.

https://doi.org/10.1111/bjh.12052

Ikeda K, Tachibana H. Clinical implication of monitoring rivaroxaban and apixaban by using anti-factor Xa assay in patients with non-valvular atrial fibrillation. J Arrhythm 2016; 32: 42-50.

https://doi.org/10.1016/j.joa.2015.08.001

Mullins CA. Recolección de la muestra. En: Rodak BF, ed. Hematología: Fundamentos y Aplicaciones Clínicas (ed 2da). Buenos Aires, Argentina: Editorial Médica Panamericana; 2005: 19-32.

Favaloro EJ, Lippi G, Raijmakers MT, Vader HL, van der Graaf F. Discard tubes are sometimes necessary when drawing samples for hemostasis. Am J Clin Pathol 2010; 134: 851.

https://doi.org/10.1309/AJCP9HIFFC6FWKYF

Adcock Funk DM, Lippi G, Favaloro EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost 2012; 38: 576-585.

https://doi.org/10.1055/s-0032-1319768

CLSI. Tubes and Additives for Venous and. Capillary Blood Specimen Collection;. Approved Standard-Sixth Edition. CLSI document H01-A6. Pensilvania, Estados Unidos: Clinical and Laboratory Standards Institute; 2010.

van Balveren JA, Huijskens MJ, Gemen EF, Pequeriaux NC, Kusters R. Effects of time and temperature on 48 routine chemistry, haematology and coagulation analytes in whole blood samples. Ann Clin Biochem 2016; nov 2 [Epub ahead of print].

https://doi.org/10.1177/0004563216665868

Heil W, Grunewald R, Amend M, Heins M. Influence of time and temperature on coagulation analytes in stored plasma. Clin Chem Lab Med 1998; 36: 459-462.

https://doi.org/10.1515/CCLM.1998.077

Bohm M, Taschner S, Kretzschmar E, Gerlach R, Favaloro EJ, Scharrer I. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Blood Coagul Fibrinolysis 2006; 17: 39-45.

https://doi.org/10.1097/01.mbc.0000198990.16598.85

Food and Drug Administration (FDA). 510(k) Substantial equivalence determination decision summary: Sysmex America, Inc.; Sysmex® XN-Series (XN-10, XN-20) Automated Hematology Analyzers. 2016. Disponible: https://www.accessdata.fda.gov/cdrh_docs/reviews/K112605.pdf. Consultado: oct 2016.

Dalby MC, Davidson SJ, Burman JF, Davies SW. Diurnal variation in platelet aggregation iwth the PFA-100 platelet function analyser. Platelets 2000; 11: 320-324.

https://doi.org/10.1080/09537100050144731

Siemens Healthcare Diagnostics Inc. Dade ® PFA Cartucho de Prueba Colágeno/EPI y Dade ® PFA Cartucho de Prueba Colágeno/ADP. Illinois, Estados Unidos. 2012.

Campuzano-Maya G. Resistencia a la aspirina: un problema de alto riesgo. Medicina & Laboratorio 2016; 22: 13-54.

Linnemann B, Schwonberg J, Rechner AR, Mani H, Lindhoff-Last E. Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y. Ann Hematol 2010; 89: 597-605.

https://doi.org/10.1007/s00277-009-0881-9

Tsantes A, Ikonomidis I, Papadakis I, Kottaridi C, Tsante A, Kalamara E, et al. Evaluation of the role of the new INNOVANCE PFA P2Y test cartridge in detection of clopidogrel resistance. Platelets 2012; 23: 481-489.

https://doi.org/10.3109/09537104.2012.689037

Kunicki TJ, Williams SA, Salomon DR, Harrison P, Crisler P, Nakagawa P, et al. Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost 2009; 7: 2116-2122.

https://doi.org/10.1111/j.1538-7836.2009.03610.x

Campuzano-Maya G. PFA-100: una nueva prueba de función plaquetaria sustituta del tiempo de sangría. Medicina & Laboratorio 2013; 19: 511-548.

Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, et al. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155: 30-44.

https://doi.org/10.1111/j.1365-2141.2011.08793.x

Hayward CP, Moffat KA, Raby A, Israels S, Plumhoff E, Flynn G, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134: 955-963.

https://doi.org/10.1309/AJCP9V3RRVNZMKDS

Guevara-Arismendy NM, Escobar-Gallo GE, Campuzano-Maya G. Utilidad clínica de la agregometría plaquetaria. Medicina & Laboratorio 2012; 18: 311-332.

Laboratorio Clínico Hematológico. Cofactor de ristocetina. Medicina & Laboratorio 2014; 20: 579-584.

Laboratorio Clínico Hematológico. Agregación plaquetaria: ácido araquidónico. Medicina & Laboratorio 2016; 22: 87-92.

Upreti S, Upreti S, Bansal R, Jeelani N, Bharat V. Types and frequency of preanalytical errors in haematology lab. J Clin Diagn Res 2013; 7: 2491-2493.

https://doi.org/10.7860/JCDR/2013/6399.3587

HarsimranKaur VN, Selhi PK, Sood N, Singh A. Preanalytical Errors in Hematology Laboratory- an Avoidable Incompetence. Iran J Pathol 2016; 11: 151-154.

Bates I, Lewis SM. Reference ranges and normal value. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 11-22.

https://doi.org/10.1016/B978-0-7020-3408-4.00002-3

Karandikar NJ, Hotchkiss EC, McKenna RW, Kroft SH. Transient stress lymphocytosis: an immunophenotypic characterization of the most common cause of newly identified adult lymphocytosis in a tertiary hospital. Am J Clin Pathol 2002; 117: 819-825.

https://doi.org/10.1309/DU0B-EBFL-3EXY-VUFP

Avloniti AA, Douda HT, Tokmakidis SP, Kortsaris AH, Papadopoulou EG, Spanoudakis EG. Acute effects of soccer training on white blood cell count in elite female players. Int J Sports Physiol Perform 2007; 2: 239-249.

https://doi.org/10.1123/ijspp.2.3.239

Lippi G, Avanzini P, Aloe R, Cervellin G. Blood collection from intravenous lines: is one drawing site better than others? Lab Med 2014; 45: 172-175.

https://doi.org/10.1309/LM2XCV5SQML1ONTM

Lima-Oliveira G, Guidi GC, Salvagno GL, Montagnana M, Rego FGM, Lippi G, et al. Is Phlebotomy Part of the Dark Side in the Clinical Laboratory Struggle for Quality? Laboratory Medicine 2012; 43: 172-176.

https://doi.org/10.1309/LMZ7YARD6ZSDIID

Vives-Corrons JL, Aguilar-Bascompte JL. Manual de técnicas de laboratorio en hematología (ed 3ra). Barcelona, España: Masson S.A.; 2006.

Buttarello M. Quality specification in haematology: the automated blood cell count. Clin Chim Acta 2004; 346: 45-54.

https://doi.org/10.1016/j.cccn.2004.02.038

Narayanan S. The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 2000; 113: 429-452.

https://doi.org/10.1309/C0NM-Q7R0-LL2E-B3UY

Briggs C, Longair I, Kumar P, Singh D, Machin SJ. Performance evaluation of the Sysmex haematology XN modular system. J Clin Pathol 2012; 65: 1024-1030.

https://doi.org/10.1136/jclinpath-2012-200930

Buoro S, Mecca T, Seghezzi M, Manenti B, Cerutti L, Dominoni P, et al. Assessment of blood sample stability for complete blood count using the Sysmex XN-9000 and Mindray BC-6800 analyzers. Rev Bras Hematol Hemoter 2016; 38: 225-239.

https://doi.org/10.1016/j.bjhh.2016.05.010

Houwen B. Blood film preparation and staining procedures. Clin Lab Med 2002; 22: 1-14, v.

https://doi.org/10.1016/S0272-2712(03)00064-7

Duboscq C, Kordich L. Efecto de la concentración de citrato de sodio sobre las pruebas de hemostasia. Acta Bioquím Clín Latinoam 2005; 39: 87-92.

Bain BJ, Lewis SM. Preparation and staining methods for blood and bone marrow films. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 57-68.

https://doi.org/10.1016/B978-0-7020-3408-4.00004-7

Riley RS, Williams D, Ross M, Zhao S, Chesney A, Clark BD, et al. Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy. J Clin Lab Anal 2009; 23: 259-307.

https://doi.org/10.1002/jcla.20305

Riley RS, Hogan TF, Pavot DR, Forysthe R, Massey D, Smith E, et al. A pathologist's perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination. J Clin Lab Anal 2004; 18: 70-90.

https://doi.org/10.1002/jcla.20008

Pagana KD, Pagana TJ. Mosby's Manual of diagnostic and Laboratory test (ed 4a). Misuri, Estados Unidos: Mosby Elsevier; 2010.

Bates I, Burthem J. Bone marrow biopsy. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 123-137.

https://doi.org/10.1016/B978-0-7020-3408-4.00007-2

Bain BJ. Bone marrow aspiration. J Clin Pathol 2001; 54: 657-663.

https://doi.org/10.1136/jcp.54.9.657

Foucar K. Procurement and Indications for Bone Marrow Examination En: Foucar K, Reichard K, Czuchlewski D, eds. Bone Marrow Pathology. Vol. 1 (ed 3a). Chicago, Estados Unidos: ASCP Press; 2010: 53-66.

Bain BJ, Clark DM, Wilkins BS. Bone Marrow Pathology (ed 4a). Nueva Jersey, Estados Unidos: Wiley-Blackwell; 2010.

https://doi.org/10.1002/9781444309782

Rodolfo P. C, Ana Carolina A. B, Annelise C. W. L, Alex F. S, Ana Paula d, Marta A. V, et al. Recomendações para garantia da qualidade em citometria de fluxo multiparamétrica: primeiro consenso do Grupo Brasileiro de Citometria de Fluxo (GBCFLUX). J Bras Patol Med Lab 2015; 51: 389-396.

Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007; 72 Suppl 1: S14-22.

https://doi.org/10.1002/cyto.b.20363

Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007; 72 Suppl 1: S5-13.

https://doi.org/10.1002/cyto.b.20365

van Dongen JJ, Lhermitte L, Bottcher S, Almeida J, van der Velden VH, Flores-Montero J, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012; 26: 1908-1975.

https://doi.org/10.1038/leu.2012.120

Karnes HE, Frater JL. A quality improvement assessment of multiple, concurrent flow cytometry analyses at a tertiary care center. Int J Lab Hematol 2015; 37: 90-97.

https://doi.org/10.1111/ijlh.12244

Stetler-Stevenson M, Yuan CM. Flow Cytometry. En: Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA, eds. Hematopathology (ed 1a). China: Saunders-Elsevier; 2011: 46-55.

https://doi.org/10.1016/B978-0-7216-0040-6.00005-8

Heins M. Quality control in the preanalytical phase of flow cytometry. Infusionsther Transfusionsmed 1996; 23: 107-108.

https://doi.org/10.1159/000223270

Bene MC, European LeukemiaNet. ELN - WP10 - Consensual recommendations on preanalytical precautions for the immunophenotyping of leukemia and immunoproliferative disorders. 2005. Disponible: https://www.leukemia-net.org/content/diagnostics/diagnostics/documents/e5821/infoboxContent5823/WP10preanayticall.pdf. Consultado: oct 2016.

Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 2010; 78: 211-230.

https://doi.org/10.1002/cyto.b.20525

Reichard K. Specialized Techniques in Bone Marrow Evaluation En: Foucar K, Reichard K, Czuchlewski D, eds. Bone Marrow Pathology. Vol. 1 (ed 3a). Chicago, Estados Unidos: ASCP Press; 2010: 67-84.

Mayall F, Darlington A, Harrison B. Fine needle aspiration cytology in the diagnosis of uncommon types of lymphoma. J Clin Pathol 2003; 56: 821-825.

https://doi.org/10.1136/jcp.56.11.821

Biesemier KW, Dent GA, Pryzwansky KB, Folds JD. A comparative study of frozen-section immunoperoxidase and flow cytometry for immunophenotypic analysis of lymph node biopsies. Clin Diagn Lab Immunol 1994; 1: 299-303.

Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry B Clin Cytom 2006; 70: 39-44.

https://doi.org/10.1002/cyto.b.20083

Keagle MB. Quality Control and Quality Assurance. En: Gersen SL, Keagle MB, eds. The Principles of Clinical Cytogenetics (ed 3a). Nueva York, Estados Unidos: Springer; 2013: 77-94.

https://doi.org/10.1007/978-1-4419-1688-4_6

Micale MA. Classical and Molecular Cytogenetic Analysis of Hematolymphoid Disorders. En: Crisan D, ed. Hematopathology: Genomic Mechanisms of Neoplastic Diseases. Nueva York, Estados Unidos: Humana Press; 2010: 39-78.

https://doi.org/10.1007/978-1-60761-262-9_2

Keagle MB, Gersen SL. Basic Cytogenetics Laboratory Procedures. En: Gersen SL, Keagle MB, eds. The Principles of Clinical Cytogenetics (ed 3a). Nueva York, Estados Unidos: Springer; 2013: 53-65.

https://doi.org/10.1007/978-1-4419-1688-4_4

Vulliamy T, Kaeda J, Foroni L, Bain BJ. Molecular and cytogenetic analysis. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 139-174.

Bulla LMC, Ambrosio EP, Martins ABT, DellaRosa VA. Viability of lymphocyte culture, at different times after blood collection, for karyotype analysis. Jornal Brasileiro de Patologia e Medicina Laboratorial 2014; 50: 124-130.

https://doi.org/10.5935/1676-2444.20140005

Morrissette JJD, Weck K, Dunphy CH. Techniques to Detect Defining Chromosomal Translocations/Abnormalities. En: Dunphy CH, ed. Molecular Pathology of Hematolymphoid Diseases. Nueva York, Estados Unidos: Springer; 2010: 129-152.

https://doi.org/10.1007/978-1-4419-5698-9_9

Barroca H, Marques C. A Basic Approach to Lymph Node and Flow Cytometry Fine-Needle Cytology. Acta Cytol 2016; 60: 284-301.

https://doi.org/10.1159/000448679

Boyanton BLJ, Rushton JR. Molecular Techniques in Hematopathology. En: Crisan D, ed. Hematopathology: Genomic Mechanisms of Neoplastic Diseases. Nueva York, Estados Unidos: Humana Press; 2010: 1-38.

https://doi.org/10.1007/978-1-60761-262-9_1

Payne DA, Baluchova K, Peoc'h KH, van Schaik RH, Chan KC, Maekawa M, et al. Pre-examination factors affecting molecular diagnostic test results and interpretation: A case-based approach. Clin Chim Acta 2016.

https://doi.org/10.1016/j.cca.2016.06.018

CLSI. Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods; Approved Guideline. CLSI document MM13-A. Pensilvania, Estados Unidos: Clinical and Laboratory Standards Institute; 2005.

Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring. Am J Hematol 2016; 91: 252-265.

https://doi.org/10.1002/ajh.24275

Mayo Medical Laboratories. Chromosomal Microarray, Hematologic Disorders. 2016. Disponible: http://www.mayomedicallaboratories.com/test-catalog/Specimen/35899. Consultado: oct 2016.

Osei-Bimpong A, Burthem J. Supplementary techniques including blood parasite diagnosis. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 101-121.

https://doi.org/10.1016/B978-0-7020-3408-4.00006-0

Sebia. HYDRAGEL IF K20 Ref. 3031. 2011. Disponible: http://www.bganalizadores.com.ar/img/3031.pdf. Consultado: oct 2016.

Jenner E. Serum free light chains in clinical laboratory diagnostics. Clin Chim Acta 2014; 427: 15-20.

https://doi.org/10.1016/j.cca.2013.08.018

Damoiseaux J. The diagnosis and classification of the cryoglobulinemic syndrome. Autoimmun Rev 2014; 13: 359-362.

https://doi.org/10.1016/j.autrev.2014.01.027

Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012; 379: 348-360.

https://doi.org/10.1016/S0140-6736(11)60242-0

Jury C, Nagai Y, Tatsumi N. Collection and handling of blood. En: Bain BJ, Bates I, Laffan MA, Lewis SM, eds. Dacie and Lewis Practical Hematology (ed 11a). China: Elsevier Churchill Livingstone; 2011: 1-9.

https://doi.org/10.1016/B978-0-7020-3408-4.00001-1

Abbott Laboratories. ARCHITECT Active-B12 (Holotranscobalamin). Wiesbaden, Alemania. 2013.

Cómo citar
1.
Guevara-Arismendy NM, Tangarife-Castaño VJ. Fase preanalítica: punto crítico en las pruebas de diagnóstico hematológico. Med. Lab. [Internet]. 1 de septiembre de 2016 [citado 30 de octubre de 2020];22(9-10):411-46. Disponible en: https://medicinaylaboratorio.com/index.php/myl/article/view/91
Publicado
2016-09-01
Sección
La Clínica y el Laboratorio